European Medicines Agency
@ema.europa.eu
23K followers 44 following 100 posts
EU regulatory authority working for public and animal health. We ensure that all medicines available on the EU market are high quality, safe and effective. Based in Amsterdam. https://www.ema.europa.eu/
Posts Media Videos Starter Packs
ema.europa.eu
EMA's October 2025 Management Board highlights are now available. The Board noted EMA's mid-year report and endorsed the first data strategy for the European medicines regulatory network. Read more here 👉https://www.ema.europa.eu/en/news/ema-management-board-highlights-october-2025-meeting
ema.europa.eu
Our safety committee, the #PRAC, has just concluded its October meeting.

PRAC responsibilities cover all aspects of the risk management of the use of medicines.

Find out more in the PRAC highlights: www.ema.europa.eu/en/news/meet...
ema.europa.eu
📢 EMA’s first reflection paper on Patient Experience Data is out!

Provide feedback and help shape how patient voices are used in medicine regulation.

🗓️ Deadline: 31 Jan 2026
🔗https://www.ema.europa.eu/en/news/path-better-include-patients-perspectives-regulation-medicines

#MedSky
A path to better include patients’ perspectives in the regulation of medicines | European Medicines Agency (EMA)
Reflection paper on patient experience data for public consultation until 31 January 2026
www.ema.europa.eu
ema.europa.eu
EDQM joins an EU initiative with EMA to strengthen medicines regulation across Sub-Saharan Africa 🌍.

This means boosting lab networks and supporting the African Medicines Agency. A big step for access to safe, quality medicines.

www.ema.europa.eu/en/partners-...

#TeamEurope #GlobalHealth
ema.europa.eu
With the European Commission and the Heads of Medicines Agencies, we have set new targets to make the EU a top destination for #clinicaltrials and speed up patient access to innovative #medicines.

👉 Learn what these targets are: www.ema.europa.eu/en/news/new-...

#MedSky
New targets for clinical trials in Europe | European Medicines Agency (EMA)
500 authorised multinational clinical trials to be added over five years
www.ema.europa.eu
ema.europa.eu
Paracetamol remains an important option to treat pain or fever in pregnant women.

Following rigorous assessment of the available scientific data, we find no evidence that taking paracetamol during pregnancy causes autism in children.

Read more 👉 www.ema.europa.eu/en/news/use-...
Use of paracetamol during pregnancy unchanged in the EU | European Medicines Agency (EMA)
Paracetamol medicines can be used in pregnancy, in accordance with official recommendations
www.ema.europa.eu
Reposted by European Medicines Agency
gasteinforum.bsky.social
Meet the #EHFG2025 speakers ⬇️

We are thrilled to welcome Emer Cooke, Executive Director of @ema.europa.eu, to our first plenary:

🤝 Rethinking solidarity in health: healing Europe's fractured social contract
🗓 1 October | 14:30-15:45 CET

💻 Register to join in person or online 👉 bit.ly/4prNqJR
ema.europa.eu
New EU variations guidelines! They'll streamline how marketing authorisations of medicines are modified and updated, making the process faster for regulators & marketing authorisation holders. Meaning quicker access to improved treatments for patients across Europe. www.ema.europa.eu/en/news/new-...
New variations guidelines to streamline lifecycle management of medicines | European Medicines Agency (EMA)
Measures to facilitate quicker processing of variations
www.ema.europa.eu
ema.europa.eu
📢 EMA recommends 14 new medicines 💊 for approval, including:

☑️ 1 medicine for respiratory syncytial virus #RSV
☑️ 1 medicine to treat vasomotor symptoms associated with #Menopause
☑️ 1 medicine to treat #Diabetestype2

www.ema.europa.eu/en/news/meet...

#PublicHealth
ema.europa.eu
Together with many European medicines authorities, we’re joining the campaign #medicinesarenotsweets🍬

Make sure you use over-the-counter medicines safely. They may be easy to buy, but they are not candy.

Find out more about the campaign: www.hma.eu/about-hma/re...
ema.europa.eu
EMA starts a review of medicines containing #levamisole, used to treat parasitic worm infections, to assess the risk of leukoencephalopathy, a condition affecting the brain.

Find out more in the #PRAC highlights 🔍 www.ema.europa.eu/en/news/meet...
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1 – 4 September 2025 | European Medicines Agency (EMA)
PRAC starts safety review of levamisole, a medicine used to treat parasitic worm infections
www.ema.europa.eu
ema.europa.eu
Flea and tick treatments for cats and dogs may have a bigger #environmental impact than previously thought. EMA seeks input for development of a new environmental risk assessment guideline for #veterinary #medicines used to control external parasites. www.ema.europa.eu/en/methodolo... #medsky
ema.europa.eu
Today EMA and WHO mark 10 years of collaboration to enhance global health. We work together to help ensure people have access to safe, effective and high-quality medicines all over the world.

Check out this overview of our key joint initiatives: www.ema.europa.eu/en/news/ema-...
EMA and WHO mark ten years of collaboration to advance global access to medicines | European Medicines Agency (EMA)
Key partnership leverages EMA’s scientific expertise and WHO’s mandate to improve access to safe and effective medicines worldwide
www.ema.europa.eu
ema.europa.eu
Are you using #finasteride tablets for hair loss?

Our safety committee confirmed suicidal thoughts as #sideeffect of these medicines and issued recommendations for #patients and healthcare professionals.

Watch and read more - www.youtube.com/watch?v=8Vhf...

#MedSky
EMA recommends measures to minimise risk of suicidal thoughts with finasteride medicines
YouTube video by European Medicines Agency
www.youtube.com
ema.europa.eu
📣 Call for expression of interest: Join EMA's first Scientific Advisory Group on Immune and Inflammatory Diseases.

Mandate duration: 3 years, upon the Committee for Medicinal Products for Human Use (CHMP) appointment.

Find out more now 👉 lnkd.in/eXXHv5nb
ema.europa.eu
Not long ago, we interviewed Bart Van der Schueren, EMA expert and obesity specialist, to discuss some of the common questions around #GLP1 receptor agonists.

One of the takeaways: GLP-1s are not an easy solution for weight loss 🚫

Watch the full interview now on YouTube: lnkd.in/dHjrTwFv
ema.europa.eu
Have you ever wondered how medicines are named? Watch this video to find out! 📹

EMA plays a crucial role in approving the names of all medicines in the EU. Clear and accurate naming is crucial for patient safety and effective healthcare delivery.

#EMA #MedSky #PublichHealth #Medicines
ema.europa.eu
EMA recommends 13 new medicines for approval:
☑️ 1 medicine for #HIV-1 pre-exposure prophylaxis #PrEP to be taken twice a year
☑️ 1 medicine to treat patients with #Niemann-Pick type C
☑️ 1 medicine to be taken orally to treat hereditary angioedema #HAE

www.ema.europa.eu/en/news/meet...
#PublicHealth
ema.europa.eu
Big news! Dr. Sabine Scherer has been elected as the new chair of EMA’s Paediatric Committee. With deep expertise in paediatric medicines & years of PDCO leadership, she’ll guide the committee’s critical work ensuring safe and effective treatments for children.
www.ema.europa.eu/en/news/ema-...
ema.europa.eu
The European Medicines Agency and the Heads of Medicines Agencies have concluded their pilot project supporting the repurposing of authorised medicines for new therapeutic uses.

Read the report to find out the key takeaways 👉 www.ema.europa.eu/en/human-reg...
ema.europa.eu
The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
www.ema.europa.eu/en/documents...
The committee highlights will be released on Friday.
www.ema.europa.eu
Reposted by European Medicines Agency
florikafinkhooijer.bsky.social
Delighted to have welcomed @ema.europa.eu in Brussels to strengthen our joint work on #MedicalCountermeasures.

From horizon scanning to supply chains – closer collaboration is key for a resilient #EuropeanHealthUnion.

Let’s turn alignment into action! 🇪🇺
ema.europa.eu
EMA concludes reviews of the Ixchiq Chikungunya vaccine, lifting restriction on vaccinating people aged 65 years and older, and of the risk of encephalitis with varicella vaccines. Stay informed 👉 www.ema.europa.eu/en/news/meet...